Summary the most recent scientific knowledge on tinnitus
This list summarize the most recent scientific knowledge on tinnitus based on 2025 publications and reviews. This includes key aspects such as prevalence, mechanisms, risk factors, treatments, and future directions.
Definition and Prevalence: Tinnitus is the perception of sound without an external stimulus, often involving emotional and cognitive components, sometimes termed "tinnitus disorder" or "auditory hallucinosis." It affects about 14-15% of adults globally, rising to 24% in older adults, with severe cases impacting 2.3%. Projections indicate the number of adults with severe tinnitus will increase from 117 million in 2024 to 183 million by 2050 due to aging populations and rising hearing loss.
Mechanisms: Tinnitus is frequently linked to dysneuroplasticity from cochlear peripheral lesions, leading to psychological distress like depression and anxiety. It shares phenomenological similarities with chronic pain, potentially triggering existential crises. Neurophysiological markers include EEG correlations with frontal beta activity for hyperacusis and parietal activity for anxiety. Astrocytes play a role in neural inflammation and plasticity in both acute and chronic forms. Hidden hearing loss (cochlear synaptopathy) can occur without detectable changes in standard audiometry, assessed via extended high-frequency tests, otoacoustic emissions, and auditory brainstem responses. Brain-derived neurotrophic factor (BDNF) is implicated in neuroplastic changes.
Risk Factors: Hearing health is the primary risk factor for both presence (explaining 12.5% of variance) and severity (3.6% of variance), including self-reported difficulties, noise exposure, and hearing aid use. For severity, neuroticism (3.7% variance), mood issues like anxiety/depression (3.0%), and sleep disorders (2.2%) are key predictors. Demographics like age (higher in older adults due to presbycusis) and sex (more in men) contribute, but physical health and socio-demographics explain less than 1%. Over time (e.g., 9-year follow-up), risk scores predict severity evolution well (AUC 0.81 for worsening to severe distress) but not presence changes, suggesting peripheral auditory or central nervous system drivers. A simple 6-item questionnaire (POST) focusing on hearing, sleep, neuroticism, and mood can stratify risk for severity progression.
Association with Cognition: In elderly populations, tinnitus is linked to cognitive impairments, with cross-sectional studies (2024-2025) showing correlations to reduced executive function, memory, and attention, particularly in those with comorbid hearing loss.
Treatments - General Efficacy: Clinical guidelines recommend tinnitus counseling, cognitive behavioral therapy (CBT), auditory therapy (e.g., sound generators, hearing aids), and tinnitus retraining therapy (TRT). Pharmacotherapy lacks strong evidence and is not recommended. Among reviewed methods, three show definitive efficacy and four probable, based on umbrella reviews of 48 meta-analyses.
Single vs. Combination Treatments: In a 2025 trial of 461 chronic tinnitus patients, all treatments (CBT, hearing aids, app-based counseling, sound therapy) improved Tinnitus Handicap Inventory (THI) scores over 12 weeks. Combinations showed slightly greater overall improvement (-14.9 vs. -11.7 points) than singles, but no synergistic effects; instead, effective treatments (e.g., CBT, hearing aids with large effects, Cohen's d >0.8) compensated for weaker ones like sound therapy (d=0.24). Combinations may aid real-world adherence, with no serious adverse events.
Digital Counseling: A 2025 multicenter trial of 204 patients found that app-based digital counseling (with CBT elements, psychoeducation, and motivational features) added to standard care significantly reduced tinnitus distress (mean difference 4.5 points on Mini-TQ-12, Hedges' g=1.1) and daily burden (g=0.5-0.8) over 10 weeks, with higher response rates (43.8% vs. 16.9%) and benefits tied to app usage. Sustained over 9 months in similar studies.
Bimodal Neuromodulation: Retrospective 2025 review of 220 patients using the Lenire device (sound therapy plus electrical tongue stimulation) showed 91.5% achieving clinically significant THI improvement (>7 points, mean -27.8) after 12 weeks, with 66.5% shifting to mild/slight severity. Safe, with 89.2% reporting benefits, replicating trial results in clinical settings.
Other Emerging Treatments: Eye movement desensitization and reprocessing (EMDR) reduce chronic tinnitus severity more than masking; integrated CBT with neurofeedback and therapy helps; AI chatbots provide reliable info. Cochlear implants, brain stimulation, and teleaudiology show promise.
Monitoring and Assessment: Daily app data can feasibly track tinnitus symptom dynamics and clinical improvements during treatment, aiding personalized care.
Future Directions: Urgent need for more research funding, focusing on pathophysiological markers (imaging, genetics, biomarkers), new technologies (AI in audiology, EEG integrations), and telehealth. Emphasis on comorbidities, objective diagnostics, and interventions for hidden hearing loss.